NCT06310161Completed
Light Therapy in End Stage Kidney Disease
Bright Light Therapy to Treat Fatigue in End Stage Kidney Disease
Source: ClinicalTrials.gov · Last updated 19 Oct 2026
Brief summary (registry, in English)
The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 2 Jan 2024
- Start date
- 1 Feb 2026
- Primary completion date
- 7 Jul 2026
- Lead sponsor
- University of Pennsylvania
- Diseases
- Chronic kidney disease
- NCT number
- NCT06310161
What you commit to
- Study type: Interventional
- Participants enrolled: 8
- From 1 Feb 2026 to the primary completion date, 7 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Eye disorders: cataracts, glaucoma, retinal disorders (e.g. macular degeneration)
- Participants with photosensitivity (e.g. epilepsy)
Other
- Hospitalized or acutely ill
Who the study is looking for
- Signed informed consent prior to initiation of any study mandated procedure
- Male and female participants ≥ 18 years of age
- Diagnosis end stage kidney disease with hemodialysis 3 times/week for at least 1 month
- Fatigue Severity Scale (FSS) \> 9 at enrollment
- Home refrigerator for salivary cortisol storage
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.